Scinai Immunotherapeutics Ltd. (SCNI) AI Dilution Summary
Updated Oct 7, 2026
Estimated cash was $1,830,459 as of 2026-09-24, rolled forward from $2,654,000 at 2026-06-30 against estimated monthly burn of $653,333. The company is funding itself through its YA II PN, Ltd. equity line and raised $1,039,000 net after the 2026-06-30 balance-sheet date. Its last offering was a private placement that closed 2026-04-27 for $2,610,000 gross.